MP
Therapeutic Areas
Hepion Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| mSEPT9 DNA Biomarker Test | Early Detection & Surveillance of Hepatocellular Carcinoma (HCC) in Cirrhosis | Commercialization / FDA Pathway |
| ctRNA Biomarker Assay | Early Diagnosis & Surveillance of Hepatocellular Carcinoma (HCC) | Assay Development / Validation |